Guardant Health (GH) PT Raised to $55 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
Go back to Guardant Health (GH) PT Raised to $55 at BTIG
January 21, 2025 1:00 PM EST
Raymond James analyst Andrew Cooper reiterated an Outperform rating and $39.00 price target on Guardant Health (NASDAQ: GH)
The analyst comments "Net-net, this coverage news offers avenues for both volume and ASP accelerations for Reveal specifically and for the broader Guardant portfolio overall.... More
January 21, 2025 1:00 PM EST
Raymond James analyst Andrew Cooper reiterated an Outperform rating and $39.00 price target on Guardant Health (NASDAQ: GH)
The analyst comments "Net-net, this coverage news offers avenues for both volume and ASP accelerations for Reveal specifically and for the broader Guardant portfolio overall.... More
January 21, 2025 11:50 AM EST
TD Cowen analyst Dan Brennan reiterated a Buy rating and $42.00 price target on Guardant Health (NASDAQ: GH).
The analyst comments "This morning GH announced its MRD test, Reveal, received MolDX coverage in the recurrence CRC setting. Mgmt guided for such approval... More
